Pilot-testing of the Japanese version of EORTC QLQ-OH17

Pilot-testing of the Japanese version of EORTC QLQ-OH17 - Pilot-testing of the Japanese version of EORTC QLQ-OH17

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011529

Enrollment

Registered

2013-08-21

Start date

2013-08-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignancy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Receiving concurrent chemotherapy or up to 3 years post treatment.

Exclusion criteria

Exclusion criteria: 1. Multiple primary tumor 2. Severe psychiatric disorder 3. Linguistic difficulty preventing patients from completing the questionnaires.

Design outcomes

Primary

Measure	Time frame
The primary outcomes associated with this study include the ability for the EORTC QLQ-OH17 to be used in Japan with confidence that the Japanese items are translated correctly and are culturally meaningful and appropriate.	—

Countries

Japan

Contacts

Public ContactTakashi Kawaguchi

Tokyo University of Pharmacy and Life Sciences Department of Practical Pharmacy

tkawa@toyaku.ac.jp042-676-1521

Outcome results